» Articles » PMID: 26070711

Trends in Timing of Prenatal Diagnosis and Abortion for Fetal Chromosomal Abnormalities

Overview
Publisher Elsevier
Date 2015 Jun 14
PMID 26070711
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Our objective was to evaluate changes in the timing of prenatal diagnosis and abortion for chromosomal abnormalities over the past 10 years.

Study Design: This retrospective review identified singleton pregnancies with fetal chromosomal abnormalities that were diagnosed from 2005-2014 and included Down syndrome, Trisomy 18, and Trisomy 13. The study period was divided into 3 intervals: 2005-2006; 2007-2011; and 2012-2014. Gestational ages at prenatal diagnosis and abortion were compared over these intervals.

Results: The 213 cases included 142 cases of Down syndrome (66.7%), 47 cases of Trisomy 18 (22.1%), and 24 cases of Trisomy 13 (11.3%). Two hundred one women (94.4%) chose to undergo abortion. The median gestational ages at prenatal diagnosis and abortion for Trisomy 18 or 13 were 12 weeks (interquartile range, 12-13 weeks) and 13 weeks (interquartile range, 12-15.5 weeks) and did not change over the study period. In contrast, in pregnancies with Down syndrome, the median gestational age at prenatal diagnosis (16, 13, and 12 weeks; P < .001) and abortion (17, 14, and 13 weeks; P < .001) both decreased significantly over the study intervals. In Down syndrome pregnancies, the proportion of women who underwent chorionic villus sampling significantly increased over the 3 study intervals (36%, 63%, and 86%; P < .001).

Conclusion: Since 2005, the gestational ages at prenatal diagnosis and abortion for Down syndrome have declined significantly. These changes are likely attributable to improvements in early screening that leads to higher rates of chorionic villus sampling.

Citing Articles

Reciprocal relationship between abortion stigma and depressive symptoms among women who underwent termination of pregnancy for fetal anomalies: a cross-lagged panel study.

Peng H, Li X, Zeng L, Wang Y, Wang Y, Qin C BMC Pregnancy Childbirth. 2025; 25(1):246.

PMID: 40055664 PMC: 11887342. DOI: 10.1186/s12884-025-07376-8.


Association Between Rates of Down Syndrome Diagnosis in States With vs Without 20-Week Abortion Bans From 2011 to 2018.

Chaiken S, Mandelbaum A, Garg B, Doshi U, Packer C, Caughey A JAMA Netw Open. 2023; 6(3):e233684.

PMID: 36943268 PMC: 10031387. DOI: 10.1001/jamanetworkopen.2023.3684.


Survival rates and outcomes of pregnancies with prenatal diagnosis of trisomy 18: A 16-year experience from a public hospital in South Africa.

Stewart C, Owusu-Bempah A, Boutall A, Barr S, Wessels T, Fieggen K Prenat Diagn. 2022; 42(13):1643-1649.

PMID: 36403096 PMC: 10098598. DOI: 10.1002/pd.6270.


Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease.

Springer S, Karner E, Worda C, Grabner M, Seidl-Mlczoch E, Laccone F Life (Basel). 2022; 12(8).

PMID: 36013402 PMC: 9410270. DOI: 10.3390/life12081223.


Uterine Septum with or without Hysteroscopic Metroplasty: Impact on Fertility and Obstetrical Outcomes-A Systematic Review and Meta-Analysis of Observational Research.

Noventa M, Spagnol G, Marchetti M, Saccardi C, Bonaldo G, Lagana A J Clin Med. 2022; 11(12).

PMID: 35743362 PMC: 9224595. DOI: 10.3390/jcm11123290.